Europe’s neurologists join forces in the European Academy of Neurology

Europe will now have just one international neurological association. The two European societies – the EFNS and the ENS – have merged during the Joint Congress of European Neurology in Istanbul to create the new European Academy of Neurology (EAN). Prof Günther Deuschl from Kiel, Germany, was elected the first President of the new organisation.

Günther Deuschl is Professor of Neurology and Chairman of the Department of...
Günther Deuschl is Professor of Neurology and Chairman of the Department of Neurology, Christian-Albrechts-Universität, Kiel

Günther Deuschl is Professor of Neurology and Chairman of the Department of Neurology, Christian-Albrechts-Universität, Kiel. His special interests include deep brain stimulation and tremor. „I am sure that this merger will move European neurology into a pole position”, the new EAN President said. "We want to stand together to fulfil the mission of this new society. It includes taking the lead in terms of neurological practice and education on this continent and defining standards of patient care in Europe, a region which is underway to harmonizing its health systems. This society also has a huge potential when it comes to promoting scientific progress in neurology and neurosciences in general.”

The General Assembly of the EAN also elected the following officers to serve on the board of the new organisation:

Vice President:
Prof Franz Fazekas, Graz, Austria

Secretary General:
Prof Didier Leys, Lille, France

Treasurer:
Prof Marianne de Visser, Amsterdam, The Netherlands

Chair Scientific Committee:
Prof Antonio Federico, Siena, Italy

Chair Liaison Committee:
Prof David Vodusek, Ljubljana, Slovenia

Member at large:
Prof Per Soelberg Sorensen, Kopenhagen, Denmark

The first EAN Congress is scheduled to take place in Berlin, Germany in June 2015.

04.06.2014

More on the subject:

Related articles

Photo

News • Taxane-induced peripheral neuropathy

New tool predicts nerve damage after breast cancer chemotherapy

Researchers have developed a tool that can predict the risk level for side effects in the nervous system of women treated for breast cancer using taxanes. This could help adapt treatment.

Photo

News • What patients can expect

Alzheimer's: New method to predict cognitive decline

Researchers have developed a model to predict cognitive decline in patients with mild cognitive impairment or mild dementia due to Alzheimer's disease. The next step is an app that uses this model.

Photo

News • Vascular and Neurosurgery

New procedure to prevent phantom pain after limb amputation

6 out of 10 people develop pain after a limb amputation. Researchers now investigate whether a preventive, relatively simple nerve surgery can prevent patients from experiencing this pain.

Related products

Subscribe to Newsletter